197 related articles for article (PubMed ID: 20205715)
61. Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.
Ramos EA; Grochoski M; Braun-Prado K; Seniski GG; Cavalli IJ; Ribeiro EM; Camargo AA; Costa FF; Klassen G
PLoS One; 2011; 6(12):e29461. PubMed ID: 22220212
[TBL] [Abstract][Full Text] [Related]
62. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
63. Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer.
Buchegger K; Riquelme I; Viscarra T; Ili C; Brebi P; Huang TH; Roa JC
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28809778
[TBL] [Abstract][Full Text] [Related]
64. A DNA methylation-based definition of biologically distinct breast cancer subtypes.
Stefansson OA; Moran S; Gomez A; Sayols S; Arribas-Jorba C; Sandoval J; Hilmarsdottir H; Olafsdottir E; Tryggvadottir L; Jonasson JG; Eyfjord J; Esteller M
Mol Oncol; 2015 Mar; 9(3):555-68. PubMed ID: 25468711
[TBL] [Abstract][Full Text] [Related]
65. Methylation of the BIN1 gene promoter CpG island associated with breast and prostate cancer.
Kuznetsova EB; Kekeeva TV; Larin SS; Zemlyakova VV; Khomyakova AV; Babenko OV; Nemtsova MV; Zaletayev DV; Strelnikov VV
J Carcinog; 2007 May; 6():9. PubMed ID: 17477881
[TBL] [Abstract][Full Text] [Related]
66. Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers.
Tessema M; Yingling CM; Grimes MJ; Thomas CL; Liu Y; Leng S; Joste N; Belinsky SA
PLoS One; 2012; 7(4):e34850. PubMed ID: 22496870
[TBL] [Abstract][Full Text] [Related]
67. NT5E CpG island methylation is a favourable breast cancer biomarker.
Lo Nigro C; Monteverde M; Lee S; Lattanzio L; Vivenza D; Comino A; Syed N; McHugh A; Wang H; Proby C; Garrone O; Merlano M; Hatzimichael E; Briasoulis E; Gojis O; Palmieri C; Jordan L; Quinlan P; Thompson A; Crook T
Br J Cancer; 2012 Jun; 107(1):75-83. PubMed ID: 22653144
[TBL] [Abstract][Full Text] [Related]
68. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer.
Fujii H; Biel MA; Zhou W; Weitzman SA; Baylin SB; Gabrielson E
Oncogene; 1998 Apr; 16(16):2159-64. PubMed ID: 9572497
[TBL] [Abstract][Full Text] [Related]
69. Promoter CpG island hypermethylation during breast cancer progression.
Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
[TBL] [Abstract][Full Text] [Related]
70. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.
Palmisano WA; Crume KP; Grimes MJ; Winters SA; Toyota M; Esteller M; Joste N; Baylin SB; Belinsky SA
Cancer Res; 2003 Aug; 63(15):4620-5. PubMed ID: 12907641
[TBL] [Abstract][Full Text] [Related]
71. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
[TBL] [Abstract][Full Text] [Related]
72. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
73. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
[TBL] [Abstract][Full Text] [Related]
74. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes.
Chen CM; Chen HL; Hsiau TH; Hsiau AH; Shi H; Brock GJ; Wei SH; Caldwell CW; Yan PS; Huang TH
Am J Pathol; 2003 Jul; 163(1):37-45. PubMed ID: 12819009
[TBL] [Abstract][Full Text] [Related]
75. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
76. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
77. MIRA-seq for DNA methylation analysis of CpG islands.
Jung M; Kadam S; Xiong W; Rauch TA; Jin SG; Pfeifer GP
Epigenomics; 2015 Aug; 7(5):695-706. PubMed ID: 25881900
[TBL] [Abstract][Full Text] [Related]
78. Curcumin modulates DNA methylation in colorectal cancer cells.
Link A; Balaguer F; Shen Y; Lozano JJ; Leung HC; Boland CR; Goel A
PLoS One; 2013; 8(2):e57709. PubMed ID: 23460897
[TBL] [Abstract][Full Text] [Related]
79. Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.
Ribarska T; Ingenwerth M; Goering W; Engers R; Schulz WA
Cancer Genomics Proteomics; 2010; 7(2):51-60. PubMed ID: 20335518
[TBL] [Abstract][Full Text] [Related]
80. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]